Etoposide in patients with rheuma-associated hemophagocytic lymphohistiocytosis / macrophage activation syndrome

Benzer Materyaller

• How to Treat Involvement of the Central Nervous System in Hemophagocytic Lymphohistiocytosis?
  Yazar:: Horne, AnnaCarin, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Cytokine active disulfide-HMGB1 increased during severe macrophage activation syndrome
  Yazar:: Schierbeck, Hanna, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Therapeutic administration of etoposide coincides with reduced systemic HMGB1 levels in macrophage activation syndrome
  Yazar:: Palmblad, Karin, ve diğerleri
  Baskı/Yayın Bilgisi: (2021)
• Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol
  Yazar:: Trottestam, Helena, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Stem cell transplantation for children with hemophagocytic lymphohistiocytosis: results from the HLH-2004 study
  Yazar:: Bergsten, Elisabet, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)